Breakthrough research identifies fibrin as key factor in preterm brain bleeds

De­spite be­ing an ear­ly crit­ic of the In­fla­tion Re­duc­tion Act, Pfiz­er told in­vestors on Mon­day that the leg­is­la­tion is like­ly to have a “mod­est” im­pact

The ranibizumab ocular implant (Susvimo) for neovascular (wet) age-related macular degeneration (nAMD) will return to the U.S. market “in the coming weeks,” Genentech announced. The

Af­ter Ace­lyrin said that a con­tract re­search or­ga­ni­za­tion and its ven­dor made “clin­i­cal tri­al ex­e­cu­tion er­rors” in a study of the biotech’s lead im­munol­o­gy treat­ment